Skip to main content

Table 3 Treatment of each group

From: Influences of different developmental periods of taurine supplements on synaptic plasticity in hippocampal CA1 area of rats following prenatal and perinatal lead exposure

 

P18–25 Groups (Postnatal 18–25 days)

P60–75 Groups (Postnatal 60–75 days)

 

Drug(s)

Exposition phase

Drug(s)

Exposition phase

Con

-a

-a

Con+Tau

Taurine

P-W

Taurine

P-L

Lead

Lead acetate

P-W

Lead acetate

P-W

Lead+PW-Tau

Lead acetate

P-W

Lead acetate

P-W

 

Taurine

P-W

Taurine

P-W

Lead+WL-Tau

-b

Lead acetate

P-W

   

Taurine

W-L

Lead+PL-Tau

Lead acetate

P-W

Lead acetate

P-W

 

Taurine

P-W

Taurine

P-L

  1. "P-W" represents "from prenatal to weaning"; "W-L" represents "from weaning to life"; "P-L" represents "from prenatal to life"; – a untreated with any drugs; – b will not be examined until postnatal day 60–75.
Back to article page

BMC Developmental Biology

ISSN: 1471-213X

Contact us